ARCHIVES

Irinotecan And Carboplatin Improve Response In NSCLC

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate committee Oks Another Cigarette Tax Hike; NCI Seeking Cancer Control Science Head

August 1, 1986

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

DeVita Heads U.S. Board Of CCCR

August 4, 1989

NCI’s International Program Growing, With More Agreements, $8 Million In Contracts And Grants

August 8, 1975